男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

CureVac fails in COVID-19 vaccine trial with 47% efficacy

By Ouyang Xueyan | chinadaily.com.cn | Updated: 2021-06-18 00:04
Share
Share - WeChat

German biotech CureVac's COVID-19 vaccine has come out of a late-stage trial with 47 percent efficacy but the health ministry has said this will not impact the country's vaccination rollout.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 台安县| 宁波市| 阜阳市| 奈曼旗| 洛扎县| 太康县| 永昌县| 错那县| 乌兰察布市| 荣昌县| 昌宁县| 达尔| 乐亭县| 闻喜县| 邳州市| 安达市| 建德市| 玉树县| 胶州市| 东阳市| 齐齐哈尔市| 华容县| 石狮市| 徐水县| 玛多县| 临沭县| 高碑店市| 宣武区| 惠来县| 政和县| 同德县| 福泉市| 安溪县| 同仁县| 芜湖县| 油尖旺区| 大姚县| 靖安县| 饶阳县| 沙洋县| 鸡东县|